Welcome to our dedicated page for National Health Investors SEC filings (Ticker: NHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for National Health Investors, Inc. (NYSE: NHI) provides direct access to the company’s official regulatory disclosures as a self-managed real estate investment trust focused on senior housing and medical facility investments. Incorporated in 1991, NHI files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K that together outline its financial condition, portfolio activity, capital structure, and risk factors.
For this senior housing and medical facility REIT, 10-K and 10-Q filings are key resources for understanding segment performance in the Real Estate Investments and Senior Housing Operating Portfolio (SHOP) segments, including rental income, interest income from mortgage and other notes receivable, and resident fees and services. These reports also reference risk considerations such as tenant concentration, regulatory exposure to Medicare and Medicaid, real estate illiquidity, access to capital, and the need to maintain REIT status.
Form 8-K filings for NHI frequently cover material events such as public offerings of senior notes, changes in board composition, investor presentations, supplemental information releases, earnings announcements, and certain tenant or lease matters. Examples include 8-Ks describing the completion of a senior notes offering governed by an indenture with restrictive covenants, notices of non-compliance and default under a master lease with a tenant, and change in control severance agreements with named executive officers.
Through this page, users can follow debt and capital markets activity, including details of senior note issuances and related indentures, as well as governance and compensation disclosures reported under Items 1.01, 2.02, 5.02, 7.01, and 8.01 of Form 8-K. Stock Titan’s tools layer AI-powered summaries on top of these filings, helping explain complex topics such as FFO reconciliations, lease structures, credit facilities, and covenant frameworks in accessible language while preserving the underlying SEC source documents for detailed review.
National Health Investors, Inc. furnished an updated investor presentation and a related press release on November 6, 2025. The materials, titled “NHI Issues Investor Update” and “National Health Investors Investor Update,” provide information for investors and are also available on the company’s website.
The company specifies that these materials are provided under Regulation FD and are furnished, not filed, meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other securities law filings unless specifically referenced.
National Health Investors, Inc. furnished an updated investor presentation and a related press release on November 6, 2025. The materials, titled “NHI Issues Investor Update” and “National Health Investors Investor Update,” provide information for investors and are also available on the company’s website.
The company specifies that these materials are provided under Regulation FD and are furnished, not filed, meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other securities law filings unless specifically referenced.
National Health Investors, Inc. furnished an updated investor presentation and a related press release on November 6, 2025. The materials, titled “NHI Issues Investor Update” and “National Health Investors Investor Update,” provide information for investors and are also available on the company’s website.
The company specifies that these materials are provided under Regulation FD and are furnished, not filed, meaning they are not subject to certain liability provisions of the Exchange Act and are not automatically incorporated into other securities law filings unless specifically referenced.
National Health Investors (NHI) furnished its Supplemental Information for the quarter ended September 30, 2025 under Regulation FD via an 8‑K.
The materials are provided as Exhibit 99.1, dated November 6, 2025, and are also available on the company’s website. The filing lists this exhibit under Item 7.01 and includes a standard exhibit index in Item 9.01.
National Health Investors (NHI) furnished its Supplemental Information for the quarter ended September 30, 2025 under Regulation FD via an 8‑K.
The materials are provided as Exhibit 99.1, dated November 6, 2025, and are also available on the company’s website. The filing lists this exhibit under Item 7.01 and includes a standard exhibit index in Item 9.01.
National Health Investors (NHI) furnished its Supplemental Information for the quarter ended September 30, 2025 under Regulation FD via an 8‑K.
The materials are provided as Exhibit 99.1, dated November 6, 2025, and are also available on the company’s website. The filing lists this exhibit under Item 7.01 and includes a standard exhibit index in Item 9.01.
National Health Investors, Inc. filed a current report to share that it issued a press release announcing its earnings for the quarter ended September 30, 2025. The company states that this earnings release, dated November 6, 2025, is included as Exhibit 99.1 and incorporated by reference. The filing is made under the Results of Operations and Financial Condition disclosure item, signaling a routine quarterly earnings update rather than a major transaction.
National Health Investors, Inc. filed a current report to share that it issued a press release announcing its earnings for the quarter ended September 30, 2025. The company states that this earnings release, dated November 6, 2025, is included as Exhibit 99.1 and incorporated by reference. The filing is made under the Results of Operations and Financial Condition disclosure item, signaling a routine quarterly earnings update rather than a major transaction.
National Health Investors, Inc. filed a current report to share that it issued a press release announcing its earnings for the quarter ended September 30, 2025. The company states that this earnings release, dated November 6, 2025, is included as Exhibit 99.1 and incorporated by reference. The filing is made under the Results of Operations and Financial Condition disclosure item, signaling a routine quarterly earnings update rather than a major transaction.
National Health Investors (NHI) filed its Q3 2025 10‑Q, showing higher quarterly profits and active portfolio repositioning. Total revenue was $89.8M vs $82.9M a year ago, driven by rental income of $62.2M, resident fees of $21.2M, and interest and other of $6.5M. Net income was $32.5M and diluted EPS was $0.69, up from $0.65. For the first nine months, revenue reached $269.8M and net income $103.0M.
Year to date, NHI closed $139.6M of acquisitions across senior housing communities, and subsequently added a $74.3M SHOP portfolio on Oct 1, 2025 and a $52.5M CCRC leased back to Senior Living on Oct 31, 2025. The quarter included transitions of seven Discovery‑affiliated properties into the SHOP segment and related straight‑line rent write‑offs reflected in rental income adjustments.
Cash from operations was $168.8M year to date, ending cash was $81.6M. Debt, net, was $1.11B, with activity including $346.2M of senior notes issued, substantial revolver and term loan repayments, and $134.9M of common equity issued. NHI declared a quarterly dividend of $0.92 per share. Shares outstanding were 47,638,502 as of Oct 31, 2025. Future minimum lease payments totaled $1.90B.
National Health Investors (NHI) filed its Q3 2025 10‑Q, showing higher quarterly profits and active portfolio repositioning. Total revenue was $89.8M vs $82.9M a year ago, driven by rental income of $62.2M, resident fees of $21.2M, and interest and other of $6.5M. Net income was $32.5M and diluted EPS was $0.69, up from $0.65. For the first nine months, revenue reached $269.8M and net income $103.0M.
Year to date, NHI closed $139.6M of acquisitions across senior housing communities, and subsequently added a $74.3M SHOP portfolio on Oct 1, 2025 and a $52.5M CCRC leased back to Senior Living on Oct 31, 2025. The quarter included transitions of seven Discovery‑affiliated properties into the SHOP segment and related straight‑line rent write‑offs reflected in rental income adjustments.
Cash from operations was $168.8M year to date, ending cash was $81.6M. Debt, net, was $1.11B, with activity including $346.2M of senior notes issued, substantial revolver and term loan repayments, and $134.9M of common equity issued. NHI declared a quarterly dividend of $0.92 per share. Shares outstanding were 47,638,502 as of Oct 31, 2025. Future minimum lease payments totaled $1.90B.
National Health Investors (NHI) filed its Q3 2025 10‑Q, showing higher quarterly profits and active portfolio repositioning. Total revenue was $89.8M vs $82.9M a year ago, driven by rental income of $62.2M, resident fees of $21.2M, and interest and other of $6.5M. Net income was $32.5M and diluted EPS was $0.69, up from $0.65. For the first nine months, revenue reached $269.8M and net income $103.0M.
Year to date, NHI closed $139.6M of acquisitions across senior housing communities, and subsequently added a $74.3M SHOP portfolio on Oct 1, 2025 and a $52.5M CCRC leased back to Senior Living on Oct 31, 2025. The quarter included transitions of seven Discovery‑affiliated properties into the SHOP segment and related straight‑line rent write‑offs reflected in rental income adjustments.
Cash from operations was $168.8M year to date, ending cash was $81.6M. Debt, net, was $1.11B, with activity including $346.2M of senior notes issued, substantial revolver and term loan repayments, and $134.9M of common equity issued. NHI declared a quarterly dividend of $0.92 per share. Shares outstanding were 47,638,502 as of Oct 31, 2025. Future minimum lease payments totaled $1.90B.
National Health Investors, Inc. completed an underwritten public offering of $350,000,000 aggregate principal amount of its 5.350% Senior Notes due 2033, fully and unconditionally guaranteed by certain subsidiaries. The notes were issued under an existing indenture with Regions Bank as trustee and were sold at 98.903% of their principal amount.
The notes are senior unsecured obligations that rank equally with the company’s other senior unsecured, unsubordinated debt, but are effectively subordinated to secured debt and structurally junior to obligations of non‑guarantor subsidiaries. Interest at 5.350% is payable semi‑annually on February 1 and August 1, beginning February 1, 2026, until maturity on February 1, 2033. The company may redeem the notes at a make‑whole price, or at 100% of principal plus accrued interest if redeemed on or after December 1, 2032.
National Health Investors (NHI) insider filings show option exercises and open-market transactions by Travis David L. The filing reports two acquisitions of 11,666 and 11,334 shares of common stock on 09/23/2025 at a reported price of $69.20 each, and a disposition of 20,765 shares on 09/23/2025 at $80.06 per share. Following the reported non-derivative transactions, the filing lists beneficial ownership totals of 33,221, 44,555, and 23,790 shares in the respective reported lines. The Form 4 also discloses detailed option holdings and exercisable schedules, including multiple tranches with exercise prices ranging from $53.41 to $73.34 and expiration dates through 2030, and shows that several option exercises on 09/23/2025 resulted in zero remaining derivative securities for those specific grants. The report is signed by the reporting person on 09/24/2025.
National Health Investors, Inc. (NHI) is selling $350.0 million of notes through a syndicate led by J.P. Morgan and other underwriters, with individual allocations listed totaling $350.0 million. As of June 30, 2025, NHI reported approximately $1,128.0 million of senior unsecured and unsubordinated indebtedness outstanding and stated that, after giving effect to this offering and intended use of proceeds, it would have no secured indebtedness and $1,135.3 million of senior unsecured and unsubordinated indebtedness on a consolidated basis. The prospectus supplement describes customary note features including redemption at 100% of principal on or after the Par Call Date plus accrued interest, and covenants requiring maintenance of total unencumbered assets of at least 150% of total unsecured indebtedness (subject to exceptions). The document summarizes portfolio exposures and receivables: a portfolio of triple-net leases to senior housing and skilled nursing tenants, and mortgages/notes receivable of $270.4 million net of allowance considerations as of June 30, 2025. The supplement cross-references NHI’s SEC filings for risk factors, financial statements and additional disclosures.
National Health Investors, Inc. (NHI) is selling $350.0 million of notes through a syndicate led by J.P. Morgan and other underwriters, with individual allocations listed totaling $350.0 million. As of June 30, 2025, NHI reported approximately $1,128.0 million of senior unsecured and unsubordinated indebtedness outstanding and stated that, after giving effect to this offering and intended use of proceeds, it would have no secured indebtedness and $1,135.3 million of senior unsecured and unsubordinated indebtedness on a consolidated basis. The prospectus supplement describes customary note features including redemption at 100% of principal on or after the Par Call Date plus accrued interest, and covenants requiring maintenance of total unencumbered assets of at least 150% of total unsecured indebtedness (subject to exceptions). The document summarizes portfolio exposures and receivables: a portfolio of triple-net leases to senior housing and skilled nursing tenants, and mortgages/notes receivable of $270.4 million net of allowance considerations as of June 30, 2025. The supplement cross-references NHI’s SEC filings for risk factors, financial statements and additional disclosures.
National Health Investors, Inc. discloses terms and portfolio metrics related to a debt securities offering and its capital structure. As of June 30, 2025, the company reported $270.4 million of mortgages and notes receivable (excluding a $17.5 million allowance for expected credit losses) and stated it had no secured indebtedness and approximately $1,128 million of senior unsecured and unsubordinated indebtedness on a consolidated basis. The prospectus supplement describes covenant terms including a requirement to maintain total unencumbered assets of at least 150% of total unsecured indebtedness, redemption mechanics for the notes, and credit facilities with a $700 million committed revolving capacity, letters of credit and swingline capacity of up to $30 million each and facility fees between 0.125% and 0.30%. The document also summarizes tax and REIT qualification rules and withholding obligations for non-U.S. holders.
National Health Investors, Inc. discloses terms and portfolio metrics related to a debt securities offering and its capital structure. As of June 30, 2025, the company reported $270.4 million of mortgages and notes receivable (excluding a $17.5 million allowance for expected credit losses) and stated it had no secured indebtedness and approximately $1,128 million of senior unsecured and unsubordinated indebtedness on a consolidated basis. The prospectus supplement describes covenant terms including a requirement to maintain total unencumbered assets of at least 150% of total unsecured indebtedness, redemption mechanics for the notes, and credit facilities with a $700 million committed revolving capacity, letters of credit and swingline capacity of up to $30 million each and facility fees between 0.125% and 0.30%. The document also summarizes tax and REIT qualification rules and withholding obligations for non-U.S. holders.
National Health Investors, Inc. filing provides exhibit and organizational detail for a registration on Form S-3, listing numerous subsidiary and property-holding entities across many states and confirming corporate governance documents and indemnification provisions. The filing references amended articles and bylaws, multiple indentures and supplemental indentures for debt securities (including a January 26, 2021 indenture and a July 7, 2025 third supplemental indenture), and legal and tax opinions from Hogan Lovells US LLP and consent from BDO USA, LLP. It describes statutory and contractual indemnification frameworks for directors, officers, general partners and managers under Maryland, Delaware, South Carolina, Idaho and other state laws, and incorporates forms for equity, debt, preferred stock, warrants and units as exhibits.
National Health Investors, Inc. notified that a tenant failed to cure identified non-monetary lease breaches by the August 29, 2025 cure deadline. On September 8, 2025, NHI sent formal written notice that the tenant remains in default under the Master Lease because the specified non-compliance was not remedied. Under the Master Lease, a remaining uncured default after the contractual 30-day cure period allows NHI to declare an Event of Default and pursue all remedies the lease permits.